Importantly, this is consistent with the fact that advanced PDA lesions are often associated with loss of p53 function (108) and further links EMT phenotypes (e.g., migration and invasion) to metabolic state and gemcitabine resistance in PDA. This evidence concerns the gene TP53 and Patent ductus arteriosus.